LeafNLP Demos
Back to explore

Report #2886415

Received Feb 23, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (2)

Syringe issueUnderdose

Symptom narrative

Underdose; during the administration of Boostrix part of the liquid came out; pharmaceutical product complaint; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of underdose in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced underdose (Verbatim: Underdose), product leakage (Verbatim: during the administration of Boostrix part of the liquid came out) and pharmaceutical product complaint (Verbatim: pharmaceutical product complaint). The outcome of the underdose, product leakage and pharmaceutical product complaint were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 13-FEB-2026. The pharmacist was asked as general question, what was the recommendations on this situation. Did the patient had to get revaccinated The batch number was not provided, and we are unable to contact the reporter.